Noninfective disorders of pinna

H8_PINNADIS

auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H61.1 Hospital discharge: ICD-9 — 3803 Cause of death: ICD-10 — H61.1 Cause of death: ICD-9 — 3803 2 out of 7 registries used, show all original rules.	91
4. Check minimum number of events None	91
5. Include endpoints None	91
6. Filter based on genotype QC (FinnGen only)	83

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H61
Name in latin: Morbositates non infectiosae auriculae

NAME	H8_PINNADIS
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H611
HD_ICD_9	3803
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H611
COD_ICD_9	3803
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Noninfective disorders of pinna based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	684	319	359
Only index persons	610	287	323
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	32.55	34.65	30.36
Only index persons	32.98	37.05	29.37

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	83	47	36
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	52.88	48.65	58.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
88: Matched controls
880

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H61.1

ICD-10 Finland

Noninfective disorders of pinna

+∞

101.9

H29

ICPC

Ear symptom/complaint other

4.9

8.2

3803B

ICD-9 Finland

Disorders of external ear, Non-infectious disorders of pinna[DEFORMATIO AURICULARIS AQCUISITA]

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

4.19

8.07

1.9

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.61

3.03

1.8

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.64

2.99

1.9

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

173

2.11

2.62

2.3

1.3

1.95

2.44

g/l

1.10

102

(3005322) IgE [Units/volume] in Serum or Plasma

2.76

2.49

1.1

1.2

202.69

955.97

u/ml

0.84

(40760888) Immunoglobulin light chains.free panel - Serum

6.54

2.40

7.0

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

101

2.27

2.39

1.5

1.4

173.33

408.89

titre

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

114

2.11

2.10

2.0

—

(3037756) Immunofixation for Serum or Plasma

5.22

2.10

2.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

3.28

2.07

1.1

1.2

5.59

5.37

u/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

512

1.81

1.70

3.1

3.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.95

1.69

1.0

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

297

1.71

1.66

2.0

1.9

1.26

1.39

mmol/l

0.40

253

(3001604) Monocytes [#/volume] in Blood

383

1.71

1.64

6.2

6.4

0.54

0.57

e9/l

0.47

336

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2.65

1.64

1.0

1.2

—

(3006315) Basophils [#/volume] in Blood

385

1.69

1.60

6.2

6.4

0.04

e9/l

0.01

337

(3013115) Eosinophils [#/volume] in Blood

397

1.68

1.55

6.0

6.4

0.19

e9/l

0.04

356

(3013650) Neutrophils [#/volume] in Blood by Automated count

427

1.68

1.54

8.0

10.8

4.66

3.86

e9/l

0.99

384

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.52

1.51

4.1

9.1

24.19

24.77

mmol/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

196

1.72

1.48

1.4

1.3

6.82

1.52

u/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3.25

1.46

1.0

1.3

—

(3023368) Bacteria identified in Blood by Culture

197

1.70

1.45

4.9

4.1

—

(40768443) Skin Pathology biopsy report

2.39

1.45

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

198

1.69

1.42

1.4

1.7

15.93

20.05

nmol/l

1.09

172

(3034770) Mitochondria Ab [Titer] in Serum

2.72

1.39

1.5

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.27

1.38

2.1

1.7

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

559

1.72

1.37

4.5

4.4

14.57

11.06

mm/h

0.71

527

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

161

1.67

1.24

2.2

2.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

231

0.58

1.11

3.3

2.9

0.00

estimate

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

575

1.59

1.06

8.6

8.9

79.03

78.17

u/l

0.07

549

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.15

1.05

2.7

2.4

24.86

23.78

mmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

240

1.52

1.04

2.3

2.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2.08

1.02

3.3

2.0

24.00

43.11

nmol/l

—

(3042936) Bacteria identified in Isolate by Culture

1.74

1.02

2.0

2.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

589

1.58

1.00

4.1

4.4

14.51

14.88

pmol/l

0.70

547

(3004588) Protein electrophoresis panel - Serum or Plasma

2.02

0.99

3.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

1.75

0.98

2.0

1.4

—

(3032080) INR in Blood by Coagulation assay

330

1.45

0.92

17.5

10.7

1.18

1.19

inr

0.07

270

(3021589) Normoblasts [#/volume] in Blood

360

1.44

0.90

11.7

10.7

0.00

0.01

e9/l

0.51

296

(3018095) Leukocytes [#/volume] in Urine

303

1.45

0.89

3.9

3.5

16.53

31.91

e6/l

0.67

214

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

202

1.49

0.87

2.4

3.6

957.23

1026.17

ng/l

0.06

172

(42870588) Differential panel, method unspecified - Blood

241

1.44

0.82

6.9

5.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.80

0.0

2.7

—

3.60

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

308

1.41

0.80

2.4

2.0

96.68

100.21

pmol/l

0.20

164

(40768793) Breast Pathology biopsy report

0.00

0.79

0.0

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

281

1.41

0.77

4.7

2.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

245

0.67

0.76

8.1

3.7

3.98

9.93

mg/mmol

—

152

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2.15

0.76

1.6

1.1

401.60

480.79

mg/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.72

0.72

2.4

2.2

—

(3015736) pH of Urine

323

1.37

0.71

2.5

3.3

5.96

6.18

0.37

187

(3012516) Albumin [Mass/volume] in Urine

238

0.69

0.65

7.2

3.2

35.79

67.30

mg/l

0.51

157

(40768804) Tissue Pathology biopsy report

290

1.34

0.62

2.7

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.53

0.59

2.1

1.9

—

(1761868) Lipid panel - Serum or Plasma

327

0.75

0.56

3.7

2.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

163

1.38

0.55

1.5

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

267

1.31

0.53

3.6

2.9

14.30

29.52

e6/l

0.78

202

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

119

1.42

0.53

3.2

2.7

3.50

1.82

e6/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.60

0.50

1.1

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.53

0.49

1.3

1.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.43

0.46

4.0

9.5

1.16

1.51

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

105

1.40

0.44

1.9

—

(3000991) Gas panel - Venous blood

1.44

0.43

3.6

9.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.42

0.43

1.1

1.5

—

(3022313) Gas panel - Capillary blood

1.55

0.42

5.2

2.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

0.00

0.41

0.0

1.4

—

4721.38

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.41

0.0

2.1

—

74.38

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.41

0.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.41

0.0

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.43

0.40

4.8

8.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.40

0.0

2.1

—

0.44

—

(40761536) Microorganisms panel - Urine sediment

1.40

0.40

3.2

2.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.45

0.40

1.6

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

315

1.24

0.39

8.5

5.7

1.21

mmol/l

0.06

300

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.39

0.0

3.6

—

51.71

—

(3019150) Specific gravity of Urine by Refractometry

172

1.29

0.39

2.6

3.6

1.02

kg/l

—

117

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.44

0.39

1.4

2.0

—

(3003694) ABO and Rh group [Type] in Blood

241

0.78

0.38

1.4

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

755

1.45

0.38

18.6

14.9

26.62

21.79

mg/l

0.46

628

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.32

0.38

3.7

3.2

—

(3044889) 12 lead EKG panel

516

1.23

0.37

4.5

3.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

356

1.23

0.37

2.5

2.7

—

estimate

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.46

0.36

3.5

10.5

25.12

24.37

mmol/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

128

1.31

0.35

3.1

2.7

0.70

1.13

e6/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.36

0.34

1.0

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

175

1.26

0.34

4.6

5.2

—

(3002256) Pathology report gross observation

1.35

0.34

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

102

1.32

0.32

3.2

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

168

1.25

0.30

1.8

1.7

1.05

1.32

mg/l

0.32

138

(46235355) HIV 1 and 2 tests - Meaningful Use set

187

1.24

0.30

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

116

0.75

0.29

1.2

1.4

—

(3018418) pH of Serum or Plasma

218

1.21

0.27

6.6

3.9

7.42

7.40

1.04

163

(3002179) Metamyelocytes/Leukocytes in Blood

0.69

0.27

3.4

5.0

—

0.87

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.29

0.26

4.3

7.4

102.67

103.16

mmol/l

0.15

(3013512) EKG study

230

1.19

0.24

3.6

3.1

—

(4024509) Urine culture

1.37

0.24

2.2

1.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

789

1.33

0.24

22.5

19.2

78.77

75.76

umol/l

0.22

778

(3030467) Casts [#/volume] in Urine by Automated count

231

1.18

0.23

3.5

2.7

0.44

0.28

e6/l

0.24

169

(40758558) Short blood count panel - Blood

231

1.18

0.23

8.7

6.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.21

0.0

1.6

—

21.91

—

(3000012) Reticulocyte production index

0.00

0.21

0.0

3.4

—

0.95

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3044941) Cell count panel - Synovial fluid

0.00

0.21

0.0

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

127

1.22

0.21

1.7

1.6

974.63

1258.07

nmol/l

—

100

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.21

0.0

5.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

6.1

—

133.46

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.20

0.0

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.20

0.0

2.6

—

5.92

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.20

0.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.20

0.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

308

0.87

0.20

3.1

3.5

0.00

estimate

—

(3025941) Bacteria identified in Stool by Culture

1.16

0.19

1.0

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.25

0.19

1.3

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

0.76

0.17

21.0

4.0

1.19

1.23

mmol/l

—

(3017181) Myelocytes/Leukocytes in Blood

0.79

0.16

2.7

4.8

—

1.23

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

114

1.16

0.12

3.3

2.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

300

0.90

0.12

4.7

3.6

20.99

30.35

ng/l

0.49

202

(3029937) Albumin [Presence] in Urine by Test strip

232

1.11

0.11

4.0

3.8

0.00

estimate

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

154

1.13

0.11

1.8

—

(3021440) Promyelocytes/Leukocytes in Blood

0.81

0.08

2.7

4.8

—

0.25

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.03

0.07

2.6

1.6

—

(3017732) Neutrophils [#/volume] in Blood

100

0.89

0.07

3.4

6.13

6.39

e9/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

109

1.12

0.06

1.7

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

131

1.08

0.04

1.4

—

(3026008) Bacteria identified in Urine by Culture

223

1.04

0.01

2.6

2.7

—

(3009261) Glucose [Presence] in Urine by Test strip

416

0.97

0.00

3.6

0.00

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

409

1.00

0.00

3.5

3.6

0.00

estimate

—

(40761511) CBC panel - Blood by Automated count

775

1.06

0.00

15.1

13.0

—

(40768797) Stomach Pathology biopsy report

1.05

0.00

1.2

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

58.40

—

(3022145) Colonoscopy Study observation

0.96

-0.00

1.0

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

12.66

—

(36660697) Celiac disease serology panel - Serum

0.91

-0.00

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

2.0

—

0.60

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

2.0

—

90.60

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

410

1.00

-0.00

3.6

0.00

estimate

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.3

—

1.20

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

75.20

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

2.3

—

10.09

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.6

—

361.60

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

50.14

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

1.3

—

(3025159) Blasts/Leukocytes in Blood

0.91

-0.00

2.7

5.4

—

0.00

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.72

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.9

—

918.00

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1650.17

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.9

—

6.03

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.3

—

106.63

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3000492) Spirometry study

1.00

-0.00

1.1

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.3

—

4.04

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

3.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

14.6

—

819.80

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

3.4

—

(4133840) Spirometry

0.00

-0.00

0.0

1.0

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

2.0

—

17.70

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

5.98

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3045414) Leukocytes [Presence] in Urine

0.90

-0.00

4.4

1.9

—

0.20

estimate

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

3.0

—

1.17

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

-0.00

0.0

1.2

—

13.20

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

170

1.00

-0.00

1.5

1.7

420.73

451.26

pmol/l

0.12

148

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.5

—

(4035726) Immunohistochemistry procedure

0.98

-0.00

1.7

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

18.6

—

1630.80

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

239.29

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

1.3

—

38.63

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PINNADIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_PINNADIS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H8_PINNADIS – Noninfective disorders of pinna

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Noninfective disorders of pinna

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints